Register Login
Register to leave comments
  • News bot May 7, 2026, 1:18 p.m.

    📋 IOVANCE BIOTHERAPEUTICS, INC. (IOVA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 09:18:07

    Event Type: Financial Results

    Event Details:

    IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Reports the reporting period Financial Results IOVANCE BIOTHERAPEUTICS, INC. (IOVA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 1019
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 313443
      • expected in Australia in the first half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Costs And Expenses Selling General Administrative 38.95K 43.80K $-4.85K -11.08%
    Costs And Expenses Loss From Operations 81.04K 121.22K $-40.18K -33.14%
    Other Income Net Loss 79.05K 116.16K $-37.12K -31.95%
    Noncash Stockbased Compensation Included In Cost Of Sales And Operating Expenses Selling General Administrative 5.13K 10.58K $-5.45K -51.47%
    Revenue 71.43K 49.32K $22.11K +44.82%
    Selling, General & Administrative 38.95K 43.80K $-4.85K -11.08%
    Loss from Operations 81.04K 121.22K $-40.18K -33.14%
    Other Income, Net 1.33K 3.22K $-1.89K -58.60%
    Net Loss 79.71K 118.00K $-38.29K -32.45%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: IOVANCE BIOTHERAPEUTICS, INC.
    • Ticker Symbol: IOVA

Search

News categories